Among the existing treatments that address insulin resistance mainly used in diabetic patients, several clinical and pre-clinical studies have assessed the effect of insulin signaling-based approaches as potential mitigators of brain dysfunction and cognitive impairment. This evidence concerns the gene INS and Insulin resistance.